(Q67905769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Double-blind comparison of etodolac and piroxicam in patients with rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

M. Schattenkirchner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1837260

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1837260

6 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://www.tandfonline.com/doi/pdf/10.1185/03007999109111660

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Current Medical Research and Opinion

6 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

497-506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

Etodolac, aspirin, and gastrointestinal microbleeding

19 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Large-scale open trials with etodolac (Lodine) in France: an assessment of safety

6 December 2022

4

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Piroxicam: a review of its pharmacological properties and therapeutic efficacy

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Etodolic acid and related compounds. Chemistry and antiinflammatory actions of some potent di- and trisubstituted 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acids

6 December 2022

9

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

6 December 2022

Clinical Therapeutics

11

5

495

Edwards W

1983

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Comparison of etodolac, aspirin and placebo for pain after oral surgery

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

The effectiveness of 100 and 200 mg etodolac (Ultradol), aspirin, and placebo in patients with pain following oral surgery

6 December 2022

15

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Anti-inflammatory and analgesic properties of etodolic acid in rats

6 December 2022

22

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Gastrointestinal Microbleeding Associated with the Use of Etodolac, Ibuprofen, Indomethacin, and Naproxen in Normal Males

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Therapeutic criteria in rheumatoid arthritis

6 December 2022

28

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy

6 December 2022

29

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

Etodolac versus naproxen in rheumatoid arthritis: a double-blind crossover study

6 December 2022

31

1 reference

https://api.crossref.org/works/10.1185/03007999109111660

6 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1837260%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference